Results 1 - 10 of 41 : 1 2 3 4 5 Next
Pharma Researchers Need a Cure
As the industry changes, Pharmaceutical Product Development and Parexel International struggle.
Taking the Drug Industry's Temperature
Covance and Icon hint at broader pharmaceutical R&D trends.
5-Star Stocks Poised to Pop: inVentiv Health
Our CAPS community gives this stock a sterling bill of health.
Cost-cutting and revenue growth make WuXi a looker for the year.
Maybe what glitters really is gold.
Covance latest results produce more optimism than did some of its contract research peers.
Maybe what glitters really is gold.
Canaries in the Drug Coal Mine
Contract research organizations like Pharmaceutical Product Development and ICON reflect an ailing drug industry.
Here's how you avoid a value trap.
Get the Best Value Stocks Right Now
3 million CAPS ratings plus 1 market slump equals 14 brilliant value stocks.